Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Infliximab/tofacitinib

Paradoxical psoriasiform reaction and herpes zoster: 2 case reports

    This is a preview of subscription content, log in to check access.

    Reference

    1. Savage KT, et al. Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients. JAAD Case Reports 6: 99-102, No. 2, Feb 2020. Available from: URL: http://doi.org/10.1016/j.jdcr.2019.10.010

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Infliximab/tofacitinib. Reactions Weekly 1791, 143 (2020). https://doi.org/10.1007/s40278-020-74988-0

    Download citation